Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'DEACON CF' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 25 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Deacon, CF; Danielson, P; Klarskov, L; Olesen, M; Holst, JJ
      Dipeptidyl peptidase IV inhibition reduces the degradation and clearance of GIP and potentiates its insulinotropic and antihyperglycemic effects in anesthetized pigs

      DIABETES
    2. Vilsboll, T; Krarup, T; Deacon, CF; Madsbad, S; Holst, JJ
      Reduced postprandial concentrations of intact biologically active gluccagon-like peptide 1 in type 2 diabetic patients

      DIABETES
    3. Meier, JJ; Huking, K; Holst, JJ; Deacon, CF; Schmiegel, WH; Nauck, MA
      Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes

      DIABETES
    4. Hartmann, B; Harr, MB; Jeppesen, PB; Wojdemann, M; Deacon, CF; Mortensen, PB; Holst, JJ
      In vivo and in vitro degradation of glucagon-like peptide-2 in humans

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    5. Deacon, CF; Nauck, MA; Meier, J; Hucking, K; Holst, JJ
      Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    6. Deacon, CF; Holst, JJ; Carr, RD
      Glucagon-like peptide-1: A basis for new approaches to the management of diabetes

      DRUGS OF TODAY
    7. Hansen, L; Deacon, CF; Orskov, C; Holst, JJ
      Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying theL cells of the porcine intestine

      ENDOCRINOLOGY
    8. DEACON CF; KNUDSEN LB; MADSEN K; WIBERG FC; JACOBSEN O; HOLST JJ
      DIPEPTIDYL PEPTIDASE-IV RESISTANT ANALOGS OF GLUCAGON-LIKE PEPTIDE-1 WHICH HAVE EXTENDED METABOLIC STABILITY AND IMPROVED BIOLOGICAL-ACTIVITY

      Diabetologia
    9. DEACON CF; RIBEL U; ROED B; HOLM HBJ; HOLST JJ; CARR RD
      GLUCAGON-LIKE PEPTIDE-1 (9-36)AMIDE DOES NOT DESENSITIZE CONSCIOUS PIGS TO THE ANTI-HYPERGLYCEMIC ACTION OF GLP-1

      Diabetologia
    10. DEACON CF; HUGHES TE; HOLST JJ
      DIPEPTIDYL-PEPTIDASE-IV INHIBITION POTENTIATES THE INSULINOTROPIC EFFECT OF GLUCAGON-LIKE PEPTIDE-1 IN THE ANESTHETIZED PIG

      Diabetes
    11. HOLST JJ; DEACON CF
      INHIBITION OF THE ACTIVITY OF DIPEPTIDYL-PEPTIDASE-IV AS A TREATMENT FOR TYPE-2 DIABETES

      Diabetes
    12. HOLST JJ; HANSEN L; ORSKOV C; WOJDEMANN M; WETIERGREN A; DEACON CF
      GLP-1 (7-36AMIDE) IS TRANSFORMED BY DIPEPTIDYL PEPTIDASE-IV IN THE CAPILLARIES SUPPLYING THE L-CELLS INTO GLP-1 (9-36AMIDE), WHICH ANTAGONIZES THE GASTROINTESTINAL EFFECTS OF GLP-1

      Diabetes
    13. DEACON CF; HUGHES TE; HOLST JJ
      DIPEPTIDYL PEPTIDASE-IV INHIBITION POTENTIATES THE INSULINOTROPIC EFFECT OF GLUCAGON-LIKE PEPTIDE-1

      Diabetes
    14. HOLST JJ; HANSEN L; DEACON CF
      THE GLP-1 RECEPTOR ANTAGONIST, GLP-1 (9-36AMIDE), IS A PRIMARY PRODUCT OF THE INTESTINAL L-CELL

      Diabetologia
    15. DEACON CF; KNUDSEN LB; JOHANSEN NL; MADSEN K; HOLST JJ
      DIPEPTIDYL PEPTIDASE-IV RESISTANT ANALOGS OF GLUCAGON-LIKE PEPTIDE-1 - IN-VITRO AND IN-VIVO STUDIES

      Diabetologia
    16. PRIDAL L; DEACON CF; KIRK O; CHRISTENSEN JV; CARR RD; HOLST JJ
      GLUCAGON-LIKE PEPTIDE-1(7-37) HAS A LARGER VOLUME OF DISTRIBUTION THAN GLUCAGON-LIKE PEPTIDE-1(7-36)AMIDE IN DOGS AND IS DEGRADED MORE QUICKLY IN-VITRO BY DOG PLASMA

      European journal of drug metabolism and pharmacokinetics
    17. DEACON CF; PRIDAL L; KLARSKOV L; OLESEN M; HOLST JJ
      GLUCAGON-LIKE PEPTIDE-1 UNDERGOES DIFFERENTIAL TISSUE-SPECIFIC METABOLISM IN THE ANESTHETIZED PIG

      American journal of physiology: endocrinology and metabolism
    18. DEACON CF; KELSTRUP M; KLARSKOV L; OLESEN M; HOLST JJ
      METABOLISM OF GLUCAGON IN THE ANESTHETIZED PIG

      Diabetes
    19. DEACON CF; JOHNSEN AH; HOLST JJ
      DEGRADATION OF GLUCAGON-LIKE PEPTIDE-1 BY HUMAN PLASMA IN-VITRO YIELDS AN N-TERMINALLY TRUNCATED PEPTIDE THAT IS A MAJOR ENDOGENOUS METABOLITE IN-VIVO

      The Journal of clinical endocrinology and metabolism
    20. DEACON CF; JOHNSEN AH; HOLST JJ
      HUMAN COLON PRODUCES FULLY PROCESSED GLUCAGON-LIKE PEPTIDE-1 (7-36)AMIDE

      FEBS letters
    21. DEACON CF; PRIDAL L; HOLST JJ
      DIFFERENTIAL ORGAN-SPECIFIC METABOLISM OF GLUCAGON-LIKE PEPTIDE-1 IN THE ANESTHETIZED PIG

      Diabetologia
    22. HOLST JJ; OLESEN KM; GUDMANDHOYER E; DEACON CF; HANSEN CP; JOHNSEN AH; MIHOLIC J; NAUCK M; QUALMANN C
      THE COLON AS A SOURCE FOR GLUCAGON-LIKE PEPTIDE-1 (GLP-1)

      Diabetologia
    23. DEACON CF; NAUCK MA; TOFTNIELSEN M; PRIDAL L; WILLMS B; HOLST JJ
      BOTH SUBCUTANEOUSLY AND INTRAVENOUSLY ADMINISTERED GLUCAGON-LIKE PEPTIDE-I ARE RAPIDLY DEGRADED FROM THE NH2-TERMINUS IN TYPE-II DIABETIC-PATIENTS AND IN HEALTHY-SUBJECTS

      Diabetes
    24. APTEL HBC; DEACON CF; HENDERSON IW
      ATRIAL-NATRIURETIC-PEPTIDE IN THE MILAN HYPERTENSIVE RAT AND THE MILAN NORMOTENSIVE RAT - PLASMA-CONCENTRATION AND BINDING TO RENAL GLOMERULI IN YOUNG, ADULT AND AGED RATS

      Journal of hypertension
    25. APTEL HBC; DEACON CF; HENDERSON IW
      INTERACTIONS OF ATRIAL-NATRIURETIC-PEPTIDE WITH A7R5 CELLS

      Biochemical and biophysical research communications


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/01/21 alle ore 01:34:58